Cargando…

ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286)

BACKGROUND: Recent randomized controlled trials comparing neoadjuvant chemoradiation plus surgery or perioperative chemotherapy plus surgery with surgery alone showed significant survival benefits for combined modality treatment of patients with localized esophageal adenocarcinoma. However, head-to-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoeppner, Jens, Lordick, Florian, Brunner, Thomas, Glatz, Torben, Bronsert, Peter, Röthling, Nadine, Schmoor, Claudia, Lorenz, Dietmar, Ell, Christian, Hopt, Ulrich T., Siewert, J. Rüdiger
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4952147/ https://www.ncbi.nlm.nih.gov/pubmed/27435280 http://dx.doi.org/10.1186/s12885-016-2564-y

Ejemplares similares

Pattern of Recurrence and Patient Survival after Perioperative Chemotherapy with 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) for Locally Advanced Esophagogastric Adenocarcinoma in Patients Treated Outside Clinical Trials
por: Glatz, Torben, et al.
Publicado: (2020)

Long-Term Postsurgical Outcomes of Neoadjuvant Chemoradiation (CROSS) Versus Chemotherapy (FLOT) for Multimodal Treatment of Adenocarcinoma of the Esophagus and the Esophagogastric Junction
por: Gebauer, Florian, et al.
Publicado: (2023)

Cancer-associated Macrophage-like Cells in Patients with Non-metastatic Adenocarcinoma of the Esophagus - Cytomorphological Heterogeneity
por: Braun, Clara, et al.
Publicado: (2023)

Perioperative FLOT chemotherapy plus surgery for oligometastatic esophagogastric adenocarcinoma: surgical outcome and overall survival
por: Runkel, Mira, et al.
Publicado: (2021)

Se maintenir à flot
por: Auer, Rebecca Ann C.
Publicado: (2021)

Cost‐effectiveness of chemoradiation followed by esophagectomy versus chemoradiation alone in squamous cell carcinoma of the esophagus
por: Salcedo, Jonathan, et al.
Publicado: (2019)

Postneoadjuvant surveillance and surgery as needed compared with postneoadjuvant surgery on principle in multimodal treatment for oesophageal cancer: a scoping review protocol
por: Schmucker, Christine, et al.
Publicado: (2021)

Un flot ininterrompu de données
por: Ourghanlian, Bernard
Publicado: (2006)

Perioperative chemotherapy versus neoadjuvant chemoradiation for patients with adenocarcinoma of the distal esophagus in Austria: a retrospective analysis
por: Koch, Oliver O., et al.
Publicado: (2019)

Complications after pancreaticoduodenectomy are associated with higher amounts of intra- and postoperative fluid therapy: A single center retrospective cohort study
por: Kulemann, Birte, et al.
Publicado: (2017)

Neoadjuvant versus definitive chemoradiation in patients with squamous cell carcinoma of the esophagus
por: Münch, Stefan, et al.
Publicado: (2019)

Results of the observational prospective RealFLOT study
por: Giommoni, Elisa, et al.
Publicado: (2021)

The roles of FLOT1 in human diseases (Review)
por: Zhan, Ziqing, et al.
Publicado: (2023)

A prospective comparative study between concurrent chemoradiation with brachytherapy boost with concurrent chemoradiation alone in locally advanced cancer esophagus
por: Tudu, Rajanigandha
Publicado: (2020)

Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma – the phase III “PREVENT”- (FLOT9) trial of the AIO /CAOGI /ACO
por: Götze, Thorsten O., et al.
Publicado: (2021)

Carmustine Wafer Implantation at the Era of Standardized Chemoradiation Protocol
por: Roux, Alexandre, et al.
Publicado: (2019)

Rationale, design, and protocol for the prevention of low back pain in the military (POLM) trial (NCT00373009)
por: George, Steven Z, et al.
Publicado: (2007)

The degree of local inflammatory response after colonic resection depends on the surgical approach: an observational study in 61 patients
por: Glatz, Torben, et al.
Publicado: (2015)

A-Part Gel, an adhesion prophylaxis for abdominal surgery: a randomized controlled phase I–II safety study [NCT00646412]
por: Lang, Reinhold, et al.
Publicado: (2015)

BALB.NCT-Cpox(nct) is a unique mouse model of hereditary coproporphyria
por: Kang, Xiaojing, et al.
Publicado: (2023)

Body composition dynamics and impact on clinical outcome in gastric and gastro-esophageal junction cancer patients undergoing perioperative chemotherapy with the FLOT protocol
por: Huemer, Florian, et al.
Publicado: (2022)

European active surveillance study of women taking HRT (EURAS-HRT): study protocol [NCT00214903]
por: Dinger, Juergen C, et al.
Publicado: (2006)

Intestinal-type of differentiation predicts favourable overall survival: confirmatory clinicopathological analysis of 198 periampullary adenocarcinomas of pancreatic, biliary, ampullary and duodenal origin
por: Bronsert, Peter, et al.
Publicado: (2013)

Delayed Posterior Reversible Leukoencephalopathy Syndrome Triggered by FLOT Chemotherapy
por: Gandini, Jordi, et al.
Publicado: (2020)

Haematological and nutritional prognostic biomarkers for patients receiving CROSS or FLOT
por: McNamee, Nicholas, et al.
Publicado: (2023)

Metastasis and Tumor Cell Migration of Solid Tumors
por: Hoeppner, Jens, et al.
Publicado: (2021)

Ruxolitinib in GvHD (RIG) study: a multicenter, randomized phase 2 trial to determine the response rate of Ruxolitinib and best available treatment (BAT) versus BAT in steroid-refractory acute graft-versus-host disease (aGvHD) (NCT02396628)
por: von Bubnoff, Nikolas, et al.
Publicado: (2018)

Renal Athersosclerotic reVascularization Evaluation (RAVE Study): Study protocol of a randomized trial [NCT00127738]
por: Tobe, Sheldon W, et al.
Publicado: (2007)

A randomized controlled trial to prevent glycemic relapse in longitudinal diabetes care: Study protocol (NCT00362193)
por: Huizinga, Mary Margaret, et al.
Publicado: (2006)

Multicentric Adenocarcinomas in a Long-Segment of Barrett’s Esophagus
por: Hartl, Stefan, et al.
Publicado: (2008)

Study Protocol of a Prospective Multicenter Study on Patient Participation for the Clinical Trial: Surgery as Needed Versus Surgery on Principle in Post-Neoadjuvant Complete Tumor Response of Esophageal Cancer (ESORES)
por: Weis, Joachim, et al.
Publicado: (2022)

Perioperative and Palliative Chemotherapy for Esophageal Cancer
por: Behrens, Angelika, et al.
Publicado: (2015)

Identification of Novel Raft Marker Protein, FlotP in Bacillus anthracis
por: Somani, Vikas K., et al.
Publicado: (2016)

FLOT2 overexpression is associated with the progression and prognosis of human colorectal cancer
por: Li, Taiyuan, et al.
Publicado: (2019)

Dynamics and Endocytosis of Flot1 in Arabidopsis Require CPI1 Function
por: Cao, Yangyang, et al.
Publicado: (2020)

Comparison of neoadjuvant chemoradiation with carboplatin/ paclitaxel or cisplatin/ 5-fluoruracil in patients with squamous cell carcinoma of the esophagus
por: Münch, Stefan, et al.
Publicado: (2017)

Factors associated with pathologic complete response following neoadjuvant chemoradiation and esophagectomy for carcinoma of esophagus and gastroesophageal junction
por: Nusrath, Syed, et al.
Publicado: (2022)

Telephone follow-up by nurse following total knee arthroplasty – protocol for a randomized clinical trial (NCT 01771315)
por: Szöts, Kirsten, et al.
Publicado: (2014)

Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus (CROSS)
por: van Heijl, M, et al.
Publicado: (2008)

Comparison of definite chemoradiation therapy with carboplatin/paclitaxel or cisplatin/5-fluoruracil in patients with squamous cell carcinoma of the esophagus
por: Münch, Stefan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_j7ugdahp0mn1ml8tt1gj5l4mtj